Page 94 - 86_04

49. Kyrou K, Hammond AM, Galizi R, Kranjc N, Burt A, Beaghton AK, Nolan
T, Crisanti A. A CRISPR-Cas9 gene drive targeting doublesex causes
complete population suppression in caged Anopheles gambiae mos-
quitoes. Nat Biotechnol. 2018; 36:1062-6.
50. Harms DW, Quadros RM, Seruggia D, Ohtsuka M, Takahashi G, Mon-
toliu L, Gurumurthy CB. Mouse Genome Editing Using the CRISPR/Cas
System. Curr Protoc Hum Genet. 2014 Oct 1;83:15.7.1-27.
51. Muñoz-Santos D, Montoliu L, Fernández A. Generation of Genetically
Modified Mice Using CRISPR/Cas9. Methods Mol Biol. 2020;
2110:129-38.
52. Fernández A, Morín M, Muñoz-Santos D, Josa S, Montero A, Rubio-
Fernández M, Cantero M, Fernández J, Del Hierro MJ, Castrillo M, Mo-
reno-Pelayo MÁ, Montoliu L. Simple Protocol for Generating and
Genotyping Genome-Edited Mice With CRISPR-Cas9 Reagents. Curr Pro-
toc Mouse Biol. 2020 Mar;10(1):e69.
53. Chneiweiss H, Hirsch F, Montoliu L, Müller AM, Fenet S, Abecassis M,
Merchant J, Baertschi B, Botbol-Baum M, Houghton JA, Kritikos M, Mif-
sud J, Bartnik E, Rath J, Druml C, Friedrich B, Carvalho AS, Lanzerath
D, Saint-Raymond A. Fostering responsible research with genome edi-
ting technologies: a European perspective. Transgenic Res. 2017;
26:709-13.
54. Montoliu L, Merchant J, Hirsch F, Abecassis M, Jouannet P, Baertschi
B, Sarrauste de Menthière C, Chneiweiss H. ARRIGE Arrives: Toward the
Responsible Use of Genome Editing. CRISPR J. 2018; 1:128-9.
55. Hirsch F, Lemaitre C, Chneiweiss H, Montoliu L. Genome Editing: Pro-
moting Responsible Research. Pharmaceut Med. 2019; 33:187-91.
56. Maeder ML, Stefanidakis M, Wilson CJ, Baral R, Barrera LA, Bounoutas
GS, Bumcrot D, Chao H, Ciulla DM, DaSilva JA, Dass A, Dhanapal V,
Fennell TJ, Friedland AE, Giannoukos G, Gloskowski SW, Glucksmann
A, Gotta GM, Jayaram H, Haskett SJ, Hopkins B, Horng JE, Joshi S,
Marco E, Mepani R, Reyon D, Ta T, Tabbaa DG, Samuelsson SJ, Shen
S, Skor MN, Stetkiewicz P, Wang T, Yudkoff C, Myer VE, Albright CF,
Jiang H. Development of a gene-editing approach to restore vision loss
in Leber congenital amaurosis type 10. Nat Med. 2019; 25:229-33.
57. Stadtmauer EA, Fraietta JA, Davis MM, Cohen AD, Weber KL, Lancaster
E, Mangan PA, Kulikovskaya I, Gupta M, Chen F, Tian L, Gonzalez VE,
Xu J, Jung IY, Melenhorst JJ, Plesa G, Shea J, Matlawski T, Cervini A,
Gaymon AL, Desjardins S, Lamontagne A, Salas-Mckee J, Fesnak A,
Siegel DL, Levine BL, Jadlowsky JK, Young RM, Chew A, Hwang WT,
Hexner EO, Carreno BM, Nobles CL, Bushman FD, Parker KR, Qi Y, Sat-
pathy AT, Chang HY, Zhao Y, Lacey SF, June CH. CRISPR-engineered T
cells in patients with refractory cancer. Science 2020; 367:eaba7365.
58. Haydar Frangoul, M.D., David Altshuler, M.D., Ph.D., M. Domenica
Cappellini, M.D., Yi-Shan Chen, Ph.D., Jennifer Domm, M.D., Brenda
K. Eustace, Ph.D., Juergen Foell, M.D., Josu de la Fuente, M.D., Ph.D.,
Stephan Grupp, M.D., Ph.D., Rupert Handgretinger, M.D., Tony W. Ho,
M.D., Antonis Kattamis, M.D., Andrew Kernytsky, Ph.D., Julie Lekstrom-
Scientific session held on november 26, 2020 to commemorate
310 the nobel awards in physiology or medicine and in chemistry 2020
Juan Ramón Lacadena, Pablo Gastaminza, Lluis Montoliu
An. Real Acad. Farm. Vol. 86. Nº4 (2020) · pp. 287- 310
ANALES
RANF
www.analesranf.com
Himes, M.D., Amanda M. Li, M.D., Franco Locatelli, M.D., Markus Y.
Mapara, M.D., Ph.D., Mariane de Montalembert, M.D., Damiano Ron-
delli, M.D., Akshay Sharma, M.B., B.S., Sujit Sheth, M.D., Sandeep
Soni, M.D., Martin H. Steinberg, M.D., Donna Wall, M.D., Angela Yen,
Ph.D., and Selim Corbacioglu, M.D. CRISPR-Cas9 Gene Editing for Sickle
Cell Disease and ß-Thalassemia. New England Journal of Medicine,
December 5, 2020, DOI: 10.1056/NEJMoa2031054
60. Broughton JP, Deng X, Yu G, Fasching CL, Servellita V, Singh J, Miao
X, Streithorst JA, Granados A, Sotomayor-Gonzalez A, Zorn K, Gopez A,
Hsu E, Gu W, Miller S, Pan CY, Guevara H, Wadford DA, Chen JS, Chiu
CY. CRISPR-Cas12-based detection of SARS-CoV-2. Nat Biotechnol.
2020; 38:870-4.
61. Joung J, Ladha A, Saito M, Kim NG, Woolley AE, Segel M, Barretto
RPJ, Ranu A, Macrae RK, Faure G, Ioannidi EI, Krajeski RN, Bruneau
R, Huang MW, Yu XG, Li JZ, Walker BD, Hung DT, Greninger AL, Jerome
KR, Gootenberg JS, Abudayyeh OO, Zhang F. Detection of SARS-CoV-2
with SHERLOCK One-Pot Testing. N Engl J Med. 2020; 383:1492-4.
62. Fozouni P, Son S, Díaz de León Derby M, Knott GJ, Gray CN, D'Ambrosio
MV, Zhao C, Switz NA, Kumar GR, Stephens SI, Boehm D, Tsou CL, Shu
J, Bhuiya A, Armstrong M, Harris AR, Chen PY, Osterloh JM, Meyer-
Franke A, Joehnk B, Walcott K, Sil A, Langelier C, Pollard KS, Crawford
ED, Puschnik AS, Phelps M, Kistler A, DeRisi JL, Doudna JA, Fletcher
DA, Ott M. Amplification-free detection of SARS-CoV-2 with CRISPR-
Cas13a and mobile phone microscopy. Cell 2020; S0092-
8674(20)31623-8. doi: 10.1016/j.cell.2020.12.001.
63. Abbott TR, Dhamdhere G, Liu Y, Lin X, Goudy L, Zeng L, Chemparathy
A, Chmura S, Heaton NS, Debs R, Pande T, Endy D, La Russa MF, Lewis
DB, Qi LS. Development of CRISPR as an Antiviral Strategy to Combat
SARS-CoV-2 and Influenza. Cell 2020; 181:865-76.
Agradecimientos
Quiero agradecer y dedicar este artículo a Francisco Juan
Martínez Mojica, por todo su trabajo de investigación básica llevado
a cabo desde la Universidad de Alicante, que permitió avanzar a
otros muchos investigadores y posibilitó la aparición de estas he-
rramientas CRISPR de edición genética que hoy todos disfrutamos.
Si desea citar nuestro artículo:
Juan Ramón Lacadena, Pablo Gastaminza, Lluis Montoliu
Sesión científica celebrada el 26 de noviembre de 2020 para conme-
morar los premios Nobel en fisiología o medicina y en química 2020
An. Real Acad. Farm. [Internet].
An. Real Acad. Farm. Vol. 86. Nº 4 (2020) · pp. 287 - 310
DOI: http://